نتایج جستجو برای: ras models

تعداد نتایج: 935979  

Journal: :JOP : Journal of the pancreas 2001
P S Leung

The circulating renin-angiotensin system (RAS) plays an important role in the maintenance of blood pressure and fluid homeostasis. Recently, there has been a shift of emphasis from the circulating RAS to the local RAS in the regulation of individual tissue functions via a paracrine and/or autocrine mechanism. In fact, a local RAS has been proposed to be present in an array of tissues including ...

Journal: :Carcinogenesis 2005
Heather S Floyd Charles L Farnsworth Nancy D Kock Melissa C Mizesko Joy L Little Stephanie T Dance Jeff Everitt Jay Tichelaar Jeffrey A Whitsett Mark Steven Miller

To determine the effects of expression of mutant Ki-ras on lung tumorigenesis, we developed a bitransgenic mouse model that expresses the human Ki-ras(G12C) allele in alveolar type II and/or Clara cells in a tetracycline-inducible, lung-specific manner. Expression of Ki-ras(G12C) caused multiple, small lung tumors over a 12-month time period. Although tumor multiplicity increased upon continued...

ژورنال: مجله دندانپزشکی 2015
امیری, هادی مرتضوی , بیژنی, علی , توکلی, سامان محسنی , صیادی, فاطمه , مرتضوی, نازنین , مهریاری, مهسا , نژاد, مینا مطلب‌ , پاشا, شقایق زاهد , کاظمی, حامد حسین ,

  Background and Aims: The purpose of the present study was to review the studies regarding serological and salivary oxidant / antioxidant status in patients with recurrent aphthous stomatitis (RAS).   Materials and Methods: The literature was searched using key words RAS, Antioxidants, Saliva, Hematinic (s) and Hematinic Acid in the last 10 years, particularly the recent 3 years (2010-2013). A...

2016
Giuliana Cavalloni Caterina Peraldo-Neia Chiara Varamo Giovanna Chiorino Francesco Sassi Massimo Aglietta Francesco Leone

Biliary tract carcinomas (BTC) are malignant tumors with limited therapeutic options. Clinical experiences with anti-EGFR therapies have produced unsatisfactory results. The strategies of combined inhibition of EGFR and MEK1/2 could be a promising therapeutic option in BTC treatment. Preclinical activity of Panitumumab and Trametinib was tested in in vitro (EGI-1, MT-CHC01 and WITT cells) and i...

Journal: :Journal of the National Cancer Institute 2002
Zhaohui Feng Wenwei Hu James X Chen Annie Pao Haiying Li William Rom Mien-Chie Hung Moon-shong Tang

BACKGROUND Mutations in ras genes are commonly found in human cancers and in animal models. Although mutations at codons 12, 13, and 61 of H-, N- and K-ras genes can activate their oncogenic function, mutations at codon 12 of K-ras are the most common mutations found among the three ras genes in human cancers. To investigate whether codon 12 of human K-ras is especially susceptible to carcinoge...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
B Jansen H Schlagbauer-Wadl H Kahr E Heere-Ress B X Mayer H Eichler H Pehamberger M Gana-Weisz E Ben-David Y Kloog K Wolff

During past decades, knowledge of melanoma biology has increased considerably. Numerous therapeutic modalities based on this knowledge are currently under investigation. Advanced melanoma, nevertheless, remains a prime example of poor treatment response that may, in part, be the consequence of activated N-Ras oncoproteins. Besides oncogenic Ras, wild-type Ras gene products also play a key role ...

Journal: :Molecular cancer therapeutics 2007
Adi Zundelevich Galit Elad-Sfadia Ronit Haklai Yoel Kloog

Aberrant Ras pathway functions contribute to the malignant phenotype of lung cancers. Inhibitors of Ras might therefore be considered as potential drugs for lung cancer therapy. Here, we show that the Ras inhibitor farnesylthiosalicylic acid (salirasib) inhibits proliferation of human lung cancer cells harboring a mutated K-ras gene (A549, H23, or HTB54) or overexpressing a growth factor recept...

Journal: :Cell 2017
Matthew E. Welsch Anna Kaplan Jennifer M. Chambers Michael E. Stokes Pieter H. Bos Arie Zask Yan Zhang Marta Sanchez-Martin Michael A. Badgley Christine S. Huang Timothy H. Tran Hemanth Akkiraju Lewis M. Brown Renu Nandakumar Serge Cremers Wan Seok Yang Liang Tong Kenneth P. Olive Adolfo Ferrando Brent R. Stockwell

Design of small molecules that disrupt protein-protein interactions, including the interaction of RAS proteins and their effectors, may provide chemical probes and therapeutic agents. We describe here the synthesis and testing of potential small-molecule pan-RAS ligands, which were designed to interact with adjacent sites on the surface of oncogenic KRAS. One compound, termed 3144, was found to...

Journal: :PLoS ONE 2009
Courtney A. Granville Regan M. Memmott Andria Balogh Jacopo Mariotti Shigeru Kawabata Wei Han Jaclyn LoPiccolo Jason Foley David J. Liewehr Seth M. Steinberg Daniel H. Fowler M. Christine Hollander Phillip A. Dennis

BACKGROUND K-Ras mutations are characteristic of human lung adenocarcinomas and occur almost exclusively in smokers. In preclinical models, K-Ras mutations are necessary for tobacco carcinogen-driven lung tumorigenesis and are sufficient to cause lung adenocarcinomas in transgenic mice. Because these mutations confer resistance to commonly used cytotoxic chemotherapies and targeted agents, effe...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه شیراز - دانشکده علوم 1391

مدلهای گارچ در فضاهای هیلبرت پایان نامه حاضر شامل دو بخش می باشد. در قسمت اول مدلهای اتورگرسیو تعمیم یافته مشروط به ناهمگنی واریانس در فضاهای هیلبرت را معرفی، مفاهیم ریاضی مورد نیاز در تحلیل این مدلها در دامنه زمان را مطرح کرده و آنها را مورد بررسی قرار می دهیم. بر اساس پیشرفتهایی که اخیرا در زمینه تئوری داده های تابعی و آماره های عملگری ایجاد شده است، فرآیندهایی که دارای مقادیر در فضاهای ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید